- Home
- TZOO vs INMB Comparison
TZOO vs INMB Comparison
Compare TZOO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZOO
- INMB
- Stock Information
- Founded
- TZOO 1998
- INMB 2015
- Country
- TZOO United States
- INMB United States
- Employees
- TZOO N/A
- INMB N/A
- Industry
- TZOO Advertising
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TZOO Consumer Discretionary
- INMB Health Care
- Exchange
- TZOO Nasdaq
- INMB Nasdaq
- Market Cap
- TZOO 166.1M
- INMB 176.5M
- IPO Year
- TZOO 2002
- INMB 2019
- Fundamental
- Price
- TZOO $13.63
- INMB $7.69
- Analyst Decision
- TZOO Strong Buy
- INMB Strong Buy
- Analyst Count
- TZOO 3
- INMB 3
- Target Price
- TZOO $25.00
- INMB $24.33
- AVG Volume (30 Days)
- TZOO 133.5K
- INMB 250.3K
- Earning Date
- TZOO 04-23-2025
- INMB 03-27-2025
- Dividend Yield
- TZOO N/A
- INMB N/A
- EPS Growth
- TZOO 27.70
- INMB N/A
- EPS
- TZOO 1.06
- INMB N/A
- Revenue
- TZOO $83,902,000.00
- INMB $14,000.00
- Revenue This Year
- TZOO $17.49
- INMB N/A
- Revenue Next Year
- TZOO $35.34
- INMB N/A
- P/E Ratio
- TZOO $12.86
- INMB N/A
- Revenue Growth
- TZOO N/A
- INMB N/A
- 52 Week Low
- TZOO $7.12
- INMB $4.32
- 52 Week High
- TZOO $24.85
- INMB $12.72
- Technical
- Relative Strength Index (RSI)
- TZOO 37.97
- INMB 46.46
- Support Level
- TZOO $14.04
- INMB $7.07
- Resistance Level
- TZOO $14.88
- INMB $7.94
- Average True Range (ATR)
- TZOO 0.71
- INMB 0.65
- MACD
- TZOO 0.16
- INMB -0.06
- Stochastic Oscillator
- TZOO 26.67
- INMB 34.03
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; and Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties. Most of the company's revenue is derived from North America.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.